PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 207 filers reported holding PORTOLA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $13,946,000 | -72.6% | 1,955,901 | -8.3% | 0.69% | -69.5% |
| Q4 2019 | $50,944,000 | -48.2% | 2,133,343 | -41.8% | 2.25% | -51.9% |
| Q3 2019 | $98,350,000 | -11.4% | 3,667,037 | -10.4% | 4.68% | -6.6% |
| Q2 2019 | $111,007,000 | -19.5% | 4,091,687 | +2.9% | 5.00% | -7.0% |
| Q1 2019 | $137,929,000 | +9.3% | 3,974,898 | -38.5% | 5.38% | -8.4% |
| Q4 2018 | $126,150,000 | +14.1% | 6,462,605 | +55.6% | 5.87% | +16.9% |
| Q3 2018 | $110,605,000 | +28.4% | 4,153,395 | +82.2% | 5.02% | +21.2% |
| Q2 2018 | $86,123,000 | +112.5% | 2,280,201 | +83.7% | 4.15% | +89.3% |
| Q1 2018 | $40,529,000 | -45.4% | 1,240,944 | -18.6% | 2.19% | -51.6% |
| Q4 2017 | $74,210,000 | +17.7% | 1,524,443 | +30.7% | 4.52% | +53.3% |
| Q3 2017 | $63,039,000 | +244.2% | 1,166,743 | +257.8% | 2.95% | +230.6% |
| Q2 2017 | $18,314,000 | -46.2% | 326,043 | -62.5% | 0.89% | -45.2% |
| Q1 2017 | $34,033,000 | – | 868,400 | – | 1.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 228,873 | $7,475,000 | 4.17% |
| PFM Health Sciences, LP | 5,326,671 | $173,969,000 | 3.54% |
| Marcus Capital, LLC | 22,950 | $750,000 | 2.76% |
| Partner Investment Management, L.P. | 72,284 | $2,361,000 | 2.55% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,240,944 | $40,529,000 | 2.19% |
| HARVEY CAPITAL MANAGEMENT INC | 158,580 | $5,179,000 | 1.94% |
| SECTORAL ASSET MANAGEMENT INC | 498,412 | $16,278,000 | 1.78% |
| Everett Capital Advisors UK LLP | 551,173 | $18,001,000 | 1.52% |
| ROSENBLUM SILVERMAN SUTTON S F INC /CA | 125,210 | $4,089,000 | 1.46% |
| Atika Capital Management LLC | 113,000 | $3,691,000 | 1.26% |